Skip to main content
Clinical Trials/ISRCTN80797849
ISRCTN80797849
Active, not recruiting
Phase 4

Clinical and radiological evaluation after anterior lumbar interbody fusion surgery with Scarlet ALT Hyperlordotic

Spineart (Switzerland)0 sites45 target enrollmentSeptember 29, 2023

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Surgical treatment of Degenerative Disk Diseases (DDD) of the lumbar spine at various contiguous level from L2 to S1
Sponsor
Spineart (Switzerland)
Enrollment
45
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 29, 2023
End Date
September 30, 2025
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Spineart (Switzerland)

Eligibility Criteria

Inclusion Criteria

  • 1\. Age \=18 years
  • 2\. Patients who received at least one Scarlet® AL\-T Hyperlordotic
  • 3\. Informed Consent Form signed

Exclusion Criteria

  • 1\. Subject who had been deprived of their freedom by administrative or legal decision or who is under guardianship
  • 2\. Subject who does not speak/understand French

Outcomes

Primary Outcomes

Not specified

Similar Trials